日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)

单次亚消融放射治疗联合全身治疗治疗转移灶≤10个的结直肠癌患者的可行性和安全性:一项多中心试点研究(NCT05375708)

Zwart, K; Braat, M N G J A; van der Baan, F H; May, A M; Roodhart, J M L; Al-Toma, D; Otten, J M M B; Los, M; Oostergo, T; Fijneman, R J A; van Dodewaard-de Jong, J M; Punt, C J A; Meijer, G; Lagendijk, J J W; Koopman, M; Intven, M; Bol, G M

Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design

采用复发监测策略(RADAR-PANC)检测胰腺导管腺癌切除术后复发性疾病:一项根据队列内试验设计开展的国际随机对照试验方案

Daamen, L A; van Goor, I W J M; Groot, V P; Andel, P C M; Brosens, L A A; Busch, O R; Cirkel, G A; Mohammad, N Haj; Heerkens, H D; de Hingh, I H J T; Hoogwater, F; van Laarhoven, H W M; Los, M; Meijer, G J; de Meijer, V E; Pande, R; Roberts, K J; Stoker, J; Stommel, M W J; van Tienhoven, G; Verdonk, R C; Verkooijen, H M; Wessels, F J; Wilmink, J W; Besselink, M G; van Santvoort, H C; Intven, M P W; Molenaar, I Q

Changes in body composition during and after adjuvant or neo-adjuvant chemotherapy in women with breast cancer stage I-IIIB compared with changes over a similar timeframe in women without cancer

与未患乳腺癌的女性在类似时间段内的身体成分变化相比,I-IIIB期乳腺癌女性在辅助或新辅助化疗期间和之后的身体成分变化情况

van den Berg, M M G A; Kok, D E; Visser, M; de Vries, J H M; de Kruif, J Th C M; de Vries, Y; Posthuma, L; Sommeijer, D W; Timmer-Bonte, A; Los, M; van Laarhoven, H W M; Kampman, E; Winkels, Renate M

Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial

全国范围内强化实施胰腺癌最佳实践治疗方案的影响(PACAP-1):一项多中心阶梯楔形整群随机对照试验

Mackay, T M; Smits, F J; Latenstein, A E J; Bogte, A; Bonsing, B A; Bos, H; Bosscha, K; Brosens, L A A; Hol, L; Busch, O R C; Creemers, G J; Curvers, W L; den Dulk, M; van Dieren, S; van Driel, L M J W; Festen, S; van Geenen, E J M; van der Geest, L G; de Groot, D J A; de Groot, J W B; Haj Mohammad, N; Haberkorn, B C M; Haver, J T; van der Harst, E; Hemmink, G J M; de Hingh, I H; Hoge, C; Homs, M Y V; van Huijgevoort, N C; Jacobs, M A J M; Kerver, E D; Liem, M S L; Los, M; Lubbinge, H; Luelmo, S A C; de Meijer, V E; Mekenkamp, L; Molenaar, I Q; van Oijen, M G H; Patijn, G A; Quispel, R; van Rijssen, L B; Römkens, T E H; van Santvoort, H C; Schreinemakers, J M J; Schut, H; Seerden, T; Stommel, M W J; Ten Tije, A J; Venneman, N G; Verdonk, R C; Verheij, J; van Vilsteren, F G I; de Vos-Geelen, J; Vulink, A; Wientjes, C; Wit, F; Wessels, F J; Zonderhuis, B; van Werkhoven, C H; van Hooft, J E; van Eijck, C H J; Wilmink, J W; van Laarhoven, H W M; Besselink, M G

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)

细胞减灭术联合腹腔热灌注化疗与姑息性全身化疗治疗腹膜播散胃癌患者的疗效比较:一项多中心随机对照试验的研究方案(PERISCOPE II)

Koemans, W J; van der Kaaij, R T; Boot, H; Buffart, T; Veenhof, A A F A; Hartemink, K J; Grootscholten, C; Snaebjornsson, P; Retel, V P; van Tinteren, H; Vanhoutvin, S; van der Noort, V; Houwink, A; Hahn, C; Huitema, A D R; Lahaye, M; Los, M; van den Barselaar, P; Imhof, O; Aalbers, A; van Dam, G M; van Etten, B; Wijnhoven, B P L; Luyer, M D P; Boerma, D; van Sandick, J W

Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands

三氟尿苷/替吡嘧啶治疗转移性结直肠癌的可行性和有效性:来自荷兰的真实世界数据

Kwakman, Johannes J M; Vink, G; Vestjens, J H; Beerepoot, L V; de Groot, J W; Jansen, R L; Opdam, F L; Boot, H; Creemers, G J; van Rooijen, J M; Los, M; Vulink, A J E; Schut, H; van Meerten, E; Baars, A; Hamberg, P; Kapiteijn, E; Sommeijer, D W; Punt, C J A; Koopman, M

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma

可切除食管或胃食管交界处腺癌患者的术前放化疗与围手术期化疗的比较

Anderegg, M C J; van der Sluis, P C; Ruurda, J P; Gisbertz, S S; Hulshof, M C C M; van Vulpen, M; Mohammed, N Haj; van Laarhoven, H W M; Wiezer, M J; Los, M; van Berge Henegouwen, M I; van Hillegersberg, R

Differences in dietary intake during chemotherapy in breast cancer patients compared to women without cancer

乳腺癌患者化疗期间的饮食摄入量与非癌症女性的饮食摄入量存在差异

de Vries, Y C; van den Berg, M M G A; de Vries, J H M; Boesveldt, S; de Kruif, J Th C M; Buist, N; Haringhuizen, A; Los, M; Sommeijer, D W; Timmer-Bonte, J H N; van Laarhoven, H W M; Visser, M; Kampman, E; Winkels, R M

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

一项随机III期研究比较了聚乙二醇化脂质体阿霉素与卡培他滨作为老年转移性乳腺癌患者一线化疗方案的疗效:荷兰乳腺癌研究组BOOG的OMEGA研究结果

Smorenburg, C H; de Groot, S M; van Leeuwen-Stok, A E; Hamaker, M E; Wymenga, A N; de Graaf, H; de Jongh, F E; Braun, J J; Los, M; Maartense, E; van Tinteren, H; Nortier, J W R; Seynaeve, C

Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death

Akt 转移到经凋亡蛋白处理的细胞核中,并参与凋亡蛋白诱导的细胞死亡。

Maddika, S; Bay, G H; Kroczak, T J; Ande, S R; Maddika, S; Wiechec, E; Gibson, S B; Los, M